The leading market experts have placed a mean price target of $126.72 on Johnson & Johnson (NYSE:JNJ) stock. This price level, which is estimated to be attained in one-year, indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $1.57 a share for the upcoming quarter and $6.69 for the current fiscal.
The technical analysis of Johnson & Johnson Common Stock plainly substantiates that the 50-day moving average of Johnson & Johnson Common Stock is $121.80, and stock is trading $-3.57 points away or -2.93% from its 50-day moving average of $121.80. Further it is trading $2.86 or +2.48% away its 200-day moving average of $115.37. Johnson & Johnson (NYSE:JNJ) 52-week high is $126.07 and the 52-week low is $89.90.
This explains if the stock moves $-7.84, it will post a 52-week high. In event of +31.51% decline, a 52-week low will be hit.
Taking the valuation aspect to emphasize the valuation of Johnson & Johnson Common Stock, shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Johnson & Johnson (NYSE:JNJ) ratio came in at 22.03.
The stock last ended the trading session at $118.23 and registered a market cap of $323.46B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Johnson & Johnson (NYSE:JNJ) PEG ratio is at 2.74.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...